Infinia

alpha-1-antitrypsin · Kamada BioPharma Limited at Fieldfisher LLP

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Infinia, covering 2018-02-16 to 2018-02-16. Get the full timeline:

Most recent: EMA Application withdrawn: Infinia (alpha-1-antitrypsin) — Kamada BioPharma Limited at Fieldfisher LLP